Anzeige
Mehr »
Login
Freitag, 15.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Solarbetriebene Krypto-Strategie lässt Aktie an einem Tag um 100% steigen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
535 Leser
Artikel bewerten:
(2)

Cantourage UK, Leading Medical Cannabis Company Forms Partnership with Premier Craft Cannabis Cultivator Plantations Cérès, Pioneering Access to Premium Medical Cannabis Flowers for UK Patients

Finanznachrichten News

In pursuit of patient-centric care, Cantourage UK broadens portfolio of high-quality, non-irradiated, 'Canadian craft' medical cannabis

LONDON , June 16, 2023 /PRNewswire/ -- Cantourage UK, a London based specialised medical cannabis importer and wholesaler, is thrilled to announce a strategic partnership with Plantations Cérès, a seasoned craft cannabis cultivator based in Quebec, Canada. This collaboration marks the third 'Craft' cultivator available to UK patients via its unique access platform. This is a decisive step towards providing patients with consistent access to high-quality, non-irradiated medical cannabis, helping patients who are trying to fulfil an unmet clinical need in the UK.

Cantourage and Plantation Ceres further solidify their partnership with entry into the UK

Plantations Cérès is a family-run company based in St-Liguori, Québec. With more than 20 years of growing experience and with the help of state-of-the-art technologies, the growers are dedicated to the cultivation of high-quality "Craft" cannabis. The guiding principle here is quality over quantity. The focus on distributing small batches from controlled cultivation pays off in consistently high quality. Their collaboration with Cantourage UK is designed to bring multiple strains of their meticulously developed medical cannabis products to UK patients, ensuring a consistent supply of superior herbal therapies.

Niall Ivers, Co-Founder & Chief Operating Officer of Cantourage UK, commented: "We focus on trying to build a positive feedback loop for all stakeholders in the UK. Through our partnership with groups like Plantations Cérès, we are confident that we can empower prescribers to provide high-quality, craft cannabis to patients. We are excited to partner with groups that have a shared passion for medical cannabis. Collectively, we are taking a significant step forward in broadening the range of high-quality, non-irradiated medical cannabis medicines available to patients in the UK & Channel Islands."

Alexandre Lachapelle, Founder of Plantations Cérès, expressed his excitement about the collaboration: "This partnership with Cantourage UK marks another milestone in our journey, bringing our high-quality craft flower to the UK's medical patients. This step fulfills our dream to extend our passion for cannabis to the European medical market."

The partnership between Cantourage UK and Plantations Cérès is a critical stride towards superior patient care, ensuring consistent access to high-quality, non-irradiated medical cannabis for UK patients, and setting a new benchmark for excellence in the industry.

About Cantourage UK

Cantourage UK is a joint venture established in January 2021 between Cantourage SE, a publicly listed European cannabis company, and NICE Partners, a London-based firm founded in 2019 by Benjy Cuby, Gabriel Newman, Joshua Cuby and Niall Ivers. Cantourage UK is committed to meeting the needs of patients across the UK by importing high-quality medical cannabis products from around the world.

Contact:
Neon Rocks PR Agency
Natasha Hassani
natasha@neonrockspr.com

Photo - https://mma.prnewswire.com/media/2100377/Cantourage_Plantation_Ceres.jpg

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cantourage-uk-leading-medical-cannabis-company-forms-partnership-with-premier-craft-cannabis-cultivator-plantations-ceres-pioneering-access-to-premium-medical-cannabis-flowers-for-uk-patients-301852590.html

© 2023 PR Newswire
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.